vs
Limoneira CO（LMNR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Limoneira CO的1.7倍（$69.8M vs $41.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -21.0%，领先405.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -2.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 3.8%）
Limoneira是总部位于美国加利福尼亚州的领先农业企业，主营柑橘、牛油果等特色农产品的种植、加工与分销，产品销往北美、亚洲、欧洲等市场，服务零售及餐饮客户，同时布局可持续土地开发相关业务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LMNR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.7倍
$41.3M
营收增速更快
RIGL
高出23.9%
-2.8%
净利率更高
RIGL
高出405.1%
-21.0%
两年增速更快
RIGL
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.3M | $69.8M |
| 净利润 | $-8.7M | $268.1M |
| 毛利率 | -15.1% | 91.5% |
| 营业利润率 | -26.8% | 33.2% |
| 净利率 | -21.0% | 384.0% |
| 营收同比 | -2.8% | 21.2% |
| 净利润同比 | -367.5% | 1769.2% |
| 每股收益（稀释后） | $-0.49 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LMNRRIGL
| Q4 25 | $41.3M | $69.8M | ||
| Q3 25 | $45.9M | $69.5M | ||
| Q2 25 | $33.6M | $101.7M | ||
| Q1 25 | $32.9M | $53.3M | ||
| Q4 24 | $42.5M | $57.6M | ||
| Q3 24 | $61.8M | $55.3M | ||
| Q2 24 | $43.3M | $36.8M | ||
| Q1 24 | $38.3M | $29.5M |
净利润LMNRRIGL
| Q4 25 | $-8.7M | $268.1M | ||
| Q3 25 | $-855.0K | $27.9M | ||
| Q2 25 | $-3.4M | $59.6M | ||
| Q1 25 | $-3.1M | $11.4M | ||
| Q4 24 | $-1.9M | $14.3M | ||
| Q3 24 | $6.6M | $12.4M | ||
| Q2 24 | $6.6M | $-1.0M | ||
| Q1 24 | $-3.6M | $-8.2M |
毛利率LMNRRIGL
| Q4 25 | -15.1% | 91.5% | ||
| Q3 25 | 8.5% | 93.2% | ||
| Q2 25 | 5.6% | 95.6% | ||
| Q1 25 | -2.0% | 91.7% | ||
| Q4 24 | 6.3% | 89.9% | ||
| Q3 24 | 26.5% | 85.5% | ||
| Q2 24 | 6.5% | 92.4% | ||
| Q1 24 | -2.0% | 93.1% |
营业利润率LMNRRIGL
| Q4 25 | -26.8% | 33.2% | ||
| Q3 25 | -1.4% | 40.9% | ||
| Q2 25 | -10.0% | 60.1% | ||
| Q1 25 | -16.3% | 23.9% | ||
| Q4 24 | -6.5% | 28.9% | ||
| Q3 24 | 14.5% | 25.4% | ||
| Q2 24 | -10.8% | 1.2% | ||
| Q1 24 | -20.2% | -23.6% |
净利率LMNRRIGL
| Q4 25 | -21.0% | 384.0% | ||
| Q3 25 | -1.9% | 40.2% | ||
| Q2 25 | -10.0% | 58.6% | ||
| Q1 25 | -9.4% | 21.5% | ||
| Q4 24 | -4.4% | 24.9% | ||
| Q3 24 | 10.7% | 22.5% | ||
| Q2 24 | 15.2% | -2.8% | ||
| Q1 24 | -9.4% | -27.9% |
每股收益（稀释后）LMNRRIGL
| Q4 25 | $-0.49 | $14.11 | ||
| Q3 25 | $-0.06 | $1.46 | ||
| Q2 25 | $-0.20 | $3.28 | ||
| Q1 25 | $-0.18 | $0.63 | ||
| Q4 24 | $-0.09 | $0.82 | ||
| Q3 24 | $0.35 | $0.70 | ||
| Q2 24 | $0.35 | $-0.06 | ||
| Q1 24 | $-0.21 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $72.5M | $52.5M |
| 股东权益账面价值 | $180.0M | $391.5M |
| 总资产 | $311.1M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.40× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LMNRRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务LMNRRIGL
| Q4 25 | $72.5M | $52.5M | ||
| Q3 25 | $63.4M | $60.0M | ||
| Q2 25 | $55.0M | $60.0M | ||
| Q1 25 | $58.0M | $60.0M | ||
| Q4 24 | $40.6M | $60.0M | ||
| Q3 24 | $40.6M | $60.0M | ||
| Q2 24 | $60.1M | $60.0M | ||
| Q1 24 | $52.1M | $60.0M |
股东权益LMNRRIGL
| Q4 25 | $180.0M | $391.5M | ||
| Q3 25 | $180.3M | $117.6M | ||
| Q2 25 | $182.7M | $81.9M | ||
| Q1 25 | $186.5M | $18.6M | ||
| Q4 24 | $191.7M | $3.3M | ||
| Q3 24 | $194.9M | $-14.6M | ||
| Q2 24 | $189.0M | $-29.9M | ||
| Q1 24 | $184.2M | $-31.7M |
总资产LMNRRIGL
| Q4 25 | $311.1M | $513.6M | ||
| Q3 25 | $299.9M | $242.5M | ||
| Q2 25 | $296.6M | $206.7M | ||
| Q1 25 | $301.4M | $176.0M | ||
| Q4 24 | $298.8M | $164.0M | ||
| Q3 24 | $307.3M | $139.4M | ||
| Q2 24 | $322.2M | $128.4M | ||
| Q1 24 | $299.6M | $126.5M |
负债/权益比LMNRRIGL
| Q4 25 | 0.40× | 0.13× | ||
| Q3 25 | 0.35× | 0.51× | ||
| Q2 25 | 0.30× | 0.73× | ||
| Q1 25 | 0.31× | 3.23× | ||
| Q4 24 | 0.21× | 18.25× | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $942.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LMNRRIGL
| Q4 25 | $942.0K | $22.0M | ||
| Q3 25 | $-3.0M | $24.0M | ||
| Q2 25 | $8.9M | $30.5M | ||
| Q1 25 | $-12.9M | $-893.0K | ||
| Q4 24 | $6.6M | $14.5M | ||
| Q3 24 | $24.6M | $21.7M | ||
| Q2 24 | $-3.0M | $302.0K | ||
| Q1 24 | $-10.3M | $-5.0M |
现金转化率LMNRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 3.73× | 1.75× | ||
| Q2 24 | -0.46× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LMNR
| Lemon Packing | $33.9M | 82% |
| Other Agribusiness | $5.8M | 14% |
| Fresh Lemons | $1.3M | 3% |
RIGL
暂无分部数据
